Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL17873979

O=C(O)C(F)(F)F.O=C(O)c1ccccc1[N+](=O)[O-]

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.56
ALDH1A1 P00352 2/20 0.54
MAPT P10636 3/20 0.52
LMNA P02545 1/20 0.52
HTT P42858 1/20 0.52
CTSD P07339 1/20 0.51
KDM4E B2RXH2 3/20 0.50
MEN1 O00255 1/20 0.50
GAA P10253 1/20 0.50
KMT2A Q03164 1/20 0.50
P2RX1 P51575 1/20 0.50
AKR1B1 P15121 1/20 0.50
AKR1C4 P17516 1/20 0.50
AKR1C3 P42330 1/20 0.50
AKR1C2 P52895 1/20 0.50
AKR1C1 Q04828 1/20 0.50
DTYMK P23919 1/20 0.46
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2D6 P10635 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23037578 0.89 TSHR (0.62) TSHRALDH1A1MAPTLMNAHTT
SCHEMBL30727560 0.89 TSHR (0.67) TSHRALDH1A1MAPTHTTCTSD
SCHEMBL78205 0.89 TSHR (0.67) TSHRALDH1A1MAPTHTTCTSD
SCHEMBL29696138 0.89 TSHR (0.67) TSHRALDH1A1MAPTHTTCTSD
Ammonia Solution, Strong SCHEMBL11058598 0.87 TSHR (0.65) TSHRALDH1A1MAPTCTSDKDM4E
SCHEMBL4588668 0.87 TSHR (0.65) TSHRALDH1A1MAPTCTSDKDM4E
SCHEMBL9125306 0.87 TSHR (0.65) TSHRALDH1A1MAPTHTTCTSD
SCHEMBL4587804 0.87 TSHR (0.65) TSHRALDH1A1MAPTHTTCTSD
SCHEMBL20377950 0.87 TSHR (0.65) TSHRALDH1A1MAPTHTTCTSD
SCHEMBL6391676 0.87 TSHR (0.65) TSHRALDH1A1MAPTHTTCTSD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3237411-A2 COMPOUNDS, COMPOSITIONS, AND METHODS FOR INCREASING CFTR ACTIVITY Proteostasis Therapeutics, Inc. (US) 2017-11-01 EP disclosed
WO-2016105485-A2 COMPOUNDS, COMPOSITIONS, AND METHODS FOR INCREASING CFTR ACTIVITY PROTEOSTASIS THERAPEUTICS, INC. (US) 2016-06-30 WO disclosed